Calpastatin ablation aggravates the molecular phenotype in cell and animal models of Huntington disease
Jonasz Jeremiasz Weber(University Hospitals of the Ruhr-University of Bochum), Huu Phuc Nguyen(University Hospitals of the Ruhr-University of Bochum), Maike Nagel(University of Tübingen), Midea Malena Ortiz-Rios(University of Tübingen), Olaf Rieß(University of Tübingen), Julian Hofmann(University of Tübingen), Simon Johannes Kloock(University of Tübingen)
Cited by 21
Related Papers
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
14-3-3 proteins in the nervous system
|Nature reviews. Neuroscience|2003|625
Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease
|Human Molecular Genetics|2005|566
<i>SNCA</i> variants are associated with increased risk for multiple system atrophy
|Annals of Neurology|2009|283
Increased susceptibility to sporadic Parkinson's disease by a certain combined ?-synuclein/apolipoprotein E genotype
|Annals of Neurology|1999|279